Tumour-therapy radio-frequency hyperthermia system applicator, intracorporeal

Tumour-therapy radio-frequency hyperthermia system applicators are intracorporeal devices used to deliver controlled heat directly to tumours via radio-frequency energy. Clinically, they target malignant or benign growths—such as those in soft tissues or organs—to induce therapeutic hyperthermia, often as part of combined treatment plans like chemotherapy or radiation therapy.

These applicators are typically single-use, catheter-based probes inserted manually or via endoscopy, often paired with real-time temperature monitoring. Regulation varies by jurisdiction, but they’re generally classified based on risk factors like invasiveness and energy delivery precision, with compliance requirements tied to safety and performance standards for thermal therapy devices.